The April 2026 reclassification news has led some online sellers to market previously restricted compounds as newly legal, but as of June 2026, compounding pharmacy access for most of these compounds is still pending formal rulemaking
Compound Specifications CAS 62304-98-7 MW 3108.28 g/mol Formula C129H215N33O55 Documentation & Lab Use Form: Lyophilized research material Documentation: Review the product label, batch records, and applicable laboratory SOPs before accessioning
Relative contraindications requiring careful consideration and enhanced medical supervision include history of pancreatitis, severe gastrointestinal disease including gastroparesis, diabetic retinopathy (requires ophthalmologic monitoring during therapy), severe kidney disease, history of suicidal ideation or severe depression, gallbladder disease or history of cholecystitis, and age under 18 years
*der Wolverine-Stack bei Peptiden ist die Kombination von TB500 (Thymosin Beta 4) mit BP-157 in der Hoffnung damit die Wundheilung zu maximieren
In a placebo controlled ingredient level study, it improved the look of skin hydration and barrier comfort and a more even tone in as little as two weeks, including a measurable reduction in water loss through the skin (Mibelle Biochemistry, ingredient level data)